| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10076494 | DEXCEL PHARMA | Stable orally disintegrating pharmaceutical compositions |
Dec, 2036
(13 years from now) | |
| US10835488 | DEXCEL PHARMA | Stable orally disintegrating pharmaceutical compositions |
Dec, 2036
(13 years from now) | |
Esomeprazole Magnesium is owned by Dexcel Pharma.
Esomeprazole Magnesium contains Esomeprazole Magnesium.
Esomeprazole Magnesium has a total of 2 drug patents out of which 0 drug patents have expired.
Esomeprazole Magnesium was authorised for market use on 20 October, 2020.
Esomeprazole Magnesium is available in tablet, orally disintegrating, delayed release;oral dosage forms.
The generics of Esomeprazole Magnesium are possible to be released after 08 December, 2036.
Drugs and Companies using ESOMEPRAZOLE MAGNESIUM ingredient
Market Authorisation Date: 20 October, 2020
Treatment: NA
Dosage: TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL
ESOMEPRAZOLE MAGNESIUM family patents
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic